Singularity.ai provides AI-enhanced pathology and biomarker services for pharmaceutical research, utilizing advanced algorithms and human expertise to deliver accurate, real-time insights during translational research and clinical trials. The platform ensures high throughput and transparency, enabling efficient data curation and analysis while maintaining regulatory compliance and result fidelity.
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
OVPASSWCFounders
Product
Problem
Pharmaceutical companies face challenges in efficiently analyzing pathology and biomarker data during translational research and clinical trials. Traditional methods can be slow, costly, and lack the transparency needed for regulatory compliance. Extracting actionable insights from complex biomedical data requires specialized expertise and advanced analytical tools.
Solution
Singularity.ai offers AI-enhanced pathology and biomarker services designed to accelerate pharmaceutical research. The platform combines advanced algorithms with human expertise to provide accurate, real-time insights. By offering a cloud-based platform, Singularity.ai provides real-time project visibility, enabling clients to track progress, review notes, and examine slides throughout the project lifecycle. The technology streamlines data curation, annotation, algorithm training, validation, and implementation. This approach ensures high throughput, transparency, and regulatory compliance, while reducing costs associated with traditional pathology and biomarker analysis.
Target Audience
The primary target audience includes pharmaceutical companies, research institutions, and clinical trial organizations involved in drug development and translational research.
Features
- AI-powered image analysis for quantitative pathology assessments
- Cloud-based platform for real-time project tracking and collaboration
- Interactive communication tools for virtual review of pathology images and biomedical data
- Algorithms developed in collaboration with leading academic medical centers
- Thoroughly validated deep-learning and neural net derived models
- Support for multimodal data analytics, prognostic and predictive biomarker modeling